Association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study-Reference-Cited by-同舟云学术

Association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study

Published:2021-12-02 Issue: Volume: Page:
ISSN:2574-173X
Container-title:Neuropsychopharmacology Reports
language:en
Short-container-title:Neuropsychopharmacol Rep

Author:

Yasui‐Furukori Norio¹^ORCID,Muraoka Hiroyuki²,Hasegawa Naomi³,Ochi Shinichiro⁴,Numata Shusuke⁵,Hori Hikaru⁶,Hishimoto Akitoyo⁷,Onitsuka Toshiaki⁸,Ohi Kazutaka⁹,Hashimoto Naoki¹⁰,Nagasawa Tatsuya¹¹,Takaesu Yoshikazu¹²^ORCID,Inagaki Takahiko¹³,Tagata Hiromi¹⁴,Tsuboi Takashi¹⁵,Kubota Chika¹⁶,Furihata Ryuji¹⁷,Iga Jun‐ichi⁴,Iida Hitoshi⁵,Miura Kenichiro³^ORCID,Matsumoto Junya³^ORCID,Yamada Hisashi¹⁸,Watanabe Koichiro¹⁵,Inada Ken²^ORCID,Shimoda Kazutaka¹,Hashimoto Ryota³^ORCID

Affiliation:

1. Department of Psychiatry Dokkyo Medical University School of Medicine Tochigi Japan

2. Department of Psychiatry Tokyo Women's Medical University Tokyo Japan

3. Department of Pathology of Mental Diseases National Institute of Mental HealthNational Center of Neurology and Psychiatry Tokyo Japan

4. Department of Neuropsychiatry, Molecules and Function Ehime University Graduate School of Medicine Ehime Japan

5. Department of Psychiatry Graduate School of Biomedical Science Tokushima University Tokushima Japan

6. Department of Psychiatry Faculty of Medicine Fukuoka University Fukuoka Japan

7. Department of Psychiatry Yokohama City University Graduate School of Medicine Kanagawa Japan

8. Department of Neuroimaging Psychiatry Graduate School of Medical Sciences Kyushu University Fukuoka Japan

9. Department of Psychiatry Gifu University Graduate School of Medicine Gifu Japan

10. Department of Psychiatry Hokkaido University Graduate School of Medicine Hokkaido Japan

11. Department of Neuro‐Psychiatry Kanazawa Medical University Kanazawa Japan

12. Department of Neuropsychiatry Graduate School of Medicine University of the Ryukyus Okinawa Japan

13. Adolescent Mental Health Service Biwako Hospital Shiga Japan

14. Department of Neuropsychiatry Toho University Graduate School of Medicine Tokyo Japan

15. Department of Neuropsychiatry Kyorin University School of Medicine Tokyo Japan

16. National Center of Neurology and Psychiatry Hospital Tokyo Japan

17. Kyoto University Health Services Kyoto Japan

18. Department of Neuropsychiatry Hyogo College of Medicine Hyogo Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Clinical Psychology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/npr2.12218

Reference21 articles.

1. Schizophrenia, just the facts. What do we know, how well do we know it?;Wyatt RJ;Schizophr Res,1988

2. Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM‐5;Barch DM;Schizophr Res,2013

3. Schizophrenia practice guidelines: international survey and comparison;Gaebel W;Br J Psychiatry,2005

4. Guidelines for the pharmacotherapy of schizophrenia in adults;Remington G;Can J Psychiatry,2017

5. Treatment‐resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology;Howes OD;Am J Psychiatry,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of the guideline education program on anticholinergic and benzodiazepine use in outpatients with schizophrenia and major depressive disorder: The effectiveness of guidelines for Dissemination and education in psychiatric treatment (EGUIDE) project;Psychiatry Research Communications;2024-02

2. Real-World Effectiveness of High-Dose Olanzapine and Clozapine for Treatment-Resistant Schizophrenia in Japan;Journal of Clinical Psychopharmacology;2024-01-26

3. Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study;Psychiatry and Clinical Neurosciences;2023-09-08

4. Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project;BMC Psychiatry;2023-06-28

5. Prescribing Trends for the Same Patients with Schizophrenia Over 20 Years;Neuropsychiatric Disease and Treatment;2023-04